山东大学教师主页张彩 The TLR-7 agonists, Imiquimod and Gardiquimod, improve DC-based immunotherapy for melanoma in mice. Home

张彩

Professor
Supervisor of Doctorate Candidates
Supervisor of Master's Candidates

Gender:Female
Alma Mater:山东大学
Education Level:With Certificate of Graduation for Doctorate Study
Degree:Doctor
Status:Employed
School/Department:药学院
Date of Employment:2008-03-31
College: Cheeloo College of Medicine, School of Pharmaceutical Sciences, School of Pharmaceutical Sciences, School of Pharmaceutical Sciences

MOBILE Version

Click:Times

The Last Update Time: ..

1HL Llz 5DC Vrm kHd UWY vQ2 iCm sas V3P e03 Qge 0z5 UML DlK kAF xG6 5IC gmp FVT

Current position: Home >> Scientific Research >> Paper Publications

The TLR-7 agonists, Imiquimod and Gardiquimod, improve DC-based immunotherapy for melanoma in mice.

Hits:

Institution:药学院

Title of Paper:The TLR-7 agonists, Imiquimod and Gardiquimod, improve DC-based immunotherapy for melanoma in mice.

Journal:CELLULAR & MOLECULAR IMMUNOLOGY

First Author:张彩

All the Authors:张建

Document Code:lw-107597

Volume:7

Issue:6

Page Number:381

Translation or Not:No

Date of Publication:2010-06

Release Time:2019-04-13

Prev One:Macrophages help NK cells to attack tumor cells by stimulatory NKG2D ligand but protect themselves from NK killing by inhibitory ligand Qa-1.

Next One:Reverse of HBV-induced immune tolerance by an immunostimulatory 3p-HBx-siRNA in a retinoic acid inducible gene I (RIG-I) -dependent manner.

Copyright All Rights Reserved Shandong University Address: No. 27 Shanda South Road, Jinan City, Shandong Province, China: 250100
Information desk: (86) - 0531-88395114
On Duty Telephone: (86) - 0531-88364731 Construction and Maintenance: Information Work Office of Shandong University